Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome.

Affuso F, Mercurio V, Ruvolo A, Pirozzi C, Micillo F, Carlomagno G, Grieco F, Fazio S.

World J Cardiol. 2012 Mar 26;4(3):77-83. doi: 10.4330/wjc.v4.i3.77.

2.

Metabolic Syndrome.

Lam DW, LeRoith D.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2015 May 19.

3.

Genistein in the metabolic syndrome: results of a randomized clinical trial.

Squadrito F, Marini H, Bitto A, Altavilla D, Polito F, Adamo EB, D'Anna R, Arcoraci V, Burnett BP, Minutoli L, Di Benedetto A, Di Vieste G, Cucinotta D, de Gregorio C, Russo S, Corrado F, Saitta A, Irace C, Corrao S, Licata G.

J Clin Endocrinol Metab. 2013 Aug;98(8):3366-74. doi: 10.1210/jc.2013-1180.

PMID:
23824420
4.

Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance.

Derosa G, Cicero AF, D'Angelo A, Ragonesi PD, Ciccarelli L, Fogari E, Salvadeo SA, Ferrari I, Gravina A, Fassi R, Fogari R.

Clin Drug Investig. 2006;26(9):529-39.

PMID:
17163286
5.

Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study.

Filippatos TD, Kiortsis DN, Liberopoulos EN, Georgoula M, Mikhailidis DP, Elisaf MS.

Curr Med Res Opin. 2005 Dec;21(12):1997-2006.

PMID:
16368051
6.

Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion.

Pérez-Rubio KG, González-Ortiz M, Martínez-Abundis E, Robles-Cervantes JA, Espinel-Bermúdez MC.

Metab Syndr Relat Disord. 2013 Oct;11(5):366-9. doi: 10.1089/met.2012.0183.

PMID:
23808999
7.

Effects of Chinese herbal medicine Yiqi Huaju Qingli Formula in metabolic syndrome patients with microalbuminuria: a randomized placebo-controlled trial.

Wang TZ, Chen Y, He YM, Fu XD, Wang Y, Xu YQ, Yang HJ, Xue HL, Liu Y, Feng XT, Zhang T, Wang WJ.

J Integr Med. 2013 May;11(3):175-83. doi: 10.3736/jintegrmed2013032.

PMID:
23743161
9.

The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study.

Sathyapalan T, Kilpatrick ES, Coady AM, Atkin SL.

J Clin Endocrinol Metab. 2009 Jan;94(1):103-8. doi: 10.1210/jc.2008-1750.

PMID:
18940877
10.

Effect of glutamine supplementation on cardiovascular risk factors in patients with type 2 diabetes.

Mansour A, Mohajeri-Tehrani MR, Qorbani M, Heshmat R, Larijani B, Hosseini S.

Nutrition. 2015 Jan;31(1):119-26. doi: 10.1016/j.nut.2014.05.014.

PMID:
25466655
11.

Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.

Marazzi G, Cacciotti L, Pelliccia F, Iaia L, Volterrani M, Caminiti G, Sposato B, Massaro R, Grieco F, Rosano G.

Adv Ther. 2011 Dec;28(12):1105-13. doi: 10.1007/s12325-011-0082-5.

PMID:
22113535
12.

Effects of policosanol on borderline to mildly elevated serum total cholesterol levels: a prospective, double-blind, placebo-controlled, parallel-group, comparative study.

Castaño G, Más R, Fernández J, López E, Illnait J, Fernández L, Mesa M.

Curr Ther Res Clin Exp. 2003 Sep;64(8):522-37. doi: 10.1016/j.curtheres.2003.09.002.

13.

Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.

Asemi Z, Foroozanfard F, Hashemi T, Bahmani F, Jamilian M, Esmaillzadeh A.

Clin Nutr. 2015 Aug;34(4):586-92. doi: 10.1016/j.clnu.2014.09.015.

PMID:
25300649
14.

Greater impairment of postprandial triacylglycerol than glucose response in metabolic syndrome subjects with fasting hyperglycaemia.

Jackson KG, Walden CM, Murray P, Smith AM, Minihane AM, Lovegrove JA, Williams CM.

Metabolism. 2013 Aug;62(8):1065-9. doi: 10.1016/j.metabol.2013.03.001.

PMID:
23598085
15.

Insulin resistance determines a differential response to changes in dietary fat modification on metabolic syndrome risk factors: the LIPGENE study.

Yubero-Serrano EM, Delgado-Lista J, Tierney AC, Perez-Martinez P, Garcia-Rios A, Alcala-Diaz JF, Castaño JP, Tinahones FJ, Drevon CA, Defoort C, Blaak EE, Dembinska-Kieć A, Risérus U, Lovegrove JA, Perez-Jimenez F, Roche HM, Lopez-Miranda J.

Am J Clin Nutr. 2015 Dec;102(6):1509-17. doi: 10.3945/ajcn.115.111286.

17.

Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo-controlled trial.

Capasso I, Esposito E, Maurea N, Montella M, Crispo A, De Laurentiis M, D'Aiuto M, Frasci G, Botti G, Grimaldi M, Cavalcanti E, Esposito G, Fucito A, Brillante G, D'Aiuto G, Ciliberto G.

Trials. 2013 Aug 28;14:273. doi: 10.1186/1745-6215-14-273.

18.

Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome.

Huptas S, Geiss HC, Otto C, Parhofer KG.

Am J Cardiol. 2006 Jul 1;98(1):66-9.

PMID:
16784923
19.
20.

Moderate replacement of carbohydrates by dietary fats affects features of metabolic syndrome: a randomized crossover clinical trial.

Rajaie S, Azadbakht L, Khazaei M, Sherbafchi M, Esmaillzadeh A.

Nutrition. 2014 Jan;30(1):61-8. doi: 10.1016/j.nut.2013.06.011.

PMID:
24290600
Items per page

Supplemental Content

Support Center